National Targeted Skin Cancer Screening Roadmap · Planning tool
Choosing who is offered regular skin checks
Targeted screening offers skin checks to adults whose risk of melanoma is above a line. ATOF helps decide where that line should sit, and whether it should sit in the same place in inner Sydney as in outback Queensland, where there may be no dermatologist for hundreds of kilometres.
What is ATOF?
A planning tool for targeted skin cancer screening in Australia. It helps decide who should be offered regular skin checks, and whether that can work in every region.
Why is it needed?
A risk calculator can estimate each adult's chance of melanoma in the next 10 years, but someone has to decide where to draw the line. Too low, and millions of people are checked who would never get melanoma, clinicians are overloaded and harmless cancers are found. Too high, and it misses the people it was meant to help.
How does it work?
For any line you choose, ATOF counts the adults above it in each of Australia's 88 regions, the clinician time their checks would take, the melanomas found earlier and the harmless ones, and the cost and health gained compared with today's skin checks.
What does it give you?
Four numbers and one plain sentence that change as you move a control: adults offered checks, regions that can deliver, the net cost a year and the cost per year of healthy life gained. The detailed calculators, methods and sources are one click away.
A planning and research tool, not advice for individuals.
Skin check threshold planner
Choose who is offered regular skin checks, who does them and how often. Every number updates as you move a control.
Start with a question
Risk thresholdThe chance of developing melanoma in the next 10 years above which an adult aged 40 or over is offered regular skin checks. A validated risk tool estimates that chance from age, skin type, moles, family history and past skin cancers. A lower threshold checks more people and finds more melanomas, but needs more clinicians and finds more harmless cancers.2.0%
0.5%: more people10%: fewer people
Who does the checksWho performs the first skin check. With GPs and nurses, 5% of checks are referred on to a dermatologist. With photography, a nurse takes total-body photographs and AI sorts them; every flagged image set is tele-reviewed by a dermatologist, and 50% of the flagged adults then see a GP in person and have a biopsy or excision. A check is assumed to find a melanoma equally often whoever does it; the choice changes clinician time, cost and the number of biopsies and excisions that follow. The small ! marks a model not yet validated: how accurately AI sorts total-body photographs in Australian primary care has not been established.
How oftenHow often each adult above the threshold is checked. More frequent checks cost more and find more of the melanomas that would progress before they would surface on their own: about 30% with checks every 5 years, 55% every 2 years and 72% every year. Melanomas that would never have caused harm stay detectable for longer, so checks find most of them at any interval: about 72% every 5 years and 93% every year. Checks at long intervals therefore bring most of the overdiagnosis but a smaller part of the benefit, and at low thresholds a programme can lose more health than it gains. Adults who already have a skin check every year are found no earlier by these checks, which replace their own. Two and five years are modelling scenarios; guidelines set no interval by risk score.
Average 10-year risk: 1.25%The share of adults aged 40 and over expected to develop a first invasive melanoma within 10 years. The default is the national average (AIHW 2025 incidence, ABS 2025 population). A higher-risk population, such as Queensland, sits nearer 2%.
Risk tool: AUC 0.69The risk calculator used to rank adults. One tool is used at a time. AUC is how well it separates people who will and will not develop melanoma: 0.5 is chance, 1 is perfect. These are the values from external validation in the 45 and Up Study.
Dermatologist review from: In-regionWho reviews referrals and flagged photographs. In-region: the region's own dermatologists. State or national: the reviews are shared across all dermatologists in the state or the country by teledermatology, so regions with few dermatologists are not overloaded.
Most of any workforce's time: 10%The most of any local workforce's clinical time the programme may use. A region can deliver if no workforce goes above it. This is a policy choice, not measured spare capacity.
Ages offered: 40 and overWho is offered a risk assessment, by age. The risk tools were validated in adults aged 45 and over (the 45 and Up Study), so starting at 40 is an extrapolation. A narrower range changes how many adults are eligible and their average risk, worked out from each region's age structure (ABS, 2024) and the national risk at each age (AIHW). It does not change the risk tool's accuracy, which is lower inside a narrow age band because age is one of its strongest predictors, or the health gained per death averted, which is larger when the people checked are younger.
from
up to
Checks below the threshold: as todayAdults below the threshold are not offered programme checks. Today 37% of them have a whole-body skin check every year (regular checkers) and the rest have none. In trials, being told one's risk did not change screening on average, and in one Australian melanoma trial women checked their skin more. So the default is no change; 10% fewer and 15% more are the published range, and 25% fewer and 35% more are stress tests. The setting changes how many checks the regular checkers have: their cost, the GP time, the biopsies and excisions that follow, and how early their melanomas are found. In the model, fewer checks at low risk save money and usually gain QALYs, because there are fewer overdiagnosed melanomas, biopsies and excisions, but a few more people die of melanoma. More checks do the opposite.
Attendance: 50%The share of adults offered checks who attend them. The default, 50%, is close to established programmes: BreastScreen Australia reaches about 50% of eligible women and the National Bowel Cancer Screening Program about 41% of the people it invites (AIHW). Those who do not attend carry on as today, so they add no workload, no cost and no benefit. Adults who already have regular skin checks are assumed to attend as often as other adults. The cost of risk-assessing every adult stays the same, so lower attendance raises the cost per year of healthy life.
Workforce year: 2024Today is the 2024 workforce (National Health Workforce Dataset). Later years use the projected number of dermatologists and GPs for each person aged 40 and over.
Value of a year of healthy life: $50kThe amount a health system is willing to pay for one quality-adjusted life year (QALY). Australia has no official figure; about $50,000 is often used.
Risk assessment: $5.00 every 10 yearsThe average cost per adult of finding out who is above the threshold (invitation, questionnaire, follow-up), for every adult aged 40 and over, and how often it is repeated. Both are assumptions with no direct source. The default is one round every 10 years, in a programme that runs for 10. A repeat round adds cost, and the model gives it no extra effect. It is the programme's fixed cost: it stays the same whatever the threshold.
$every
Keratinocyte cancers: cost of treating earlierWhole-body checks also find keratinocyte cancers (basal and squamous cell carcinoma), which are then removed: after 3.4 of every 100 GP skin checks (Goldsbury 2024), at about $426 each (2026 MBS fees, excision with pathology and a results consultation). Only the extra checks count: programme checks less the regular checkers' own checks they replace. Most of these cancers would have been treated later anyway, so by default only the cost of treating them 1 to 3 years earlier is counted, about 14% of the full cost. The full cost is an upper bound.
Treatment savings: countedFinding melanoma earlier avoids some treatment for advanced disease, which is expensive. Counting that saving is the standard approach. Untick it to see the programme's own budget.
ResultAt a 2.0% threshold, with GPs and practice nurses doing the checks every 5 years, about 2.12 million adults would be offered checks, 50% of them would attend, and 87 of 88 regions could deliver them. The programme would cost about $17M a year more than today. It would avert about 104 melanoma deaths over 10 years, but overdiagnosis, biopsies and excisions would take away more health than that adds, so there is no net health gain.
Adults offered checks
Adults aged 40 and over who have never had melanoma and whose risk score is above the threshold. 50% of them are assumed to attend their checks; the rest carry on as today.
2.12 million
16% of adults 40+; 1.06 million attend (50%)
Regions that can deliver
Regions where no local workforce would need more than 10% of its clinical time for the checks. The limit is under More settings. Dermatologist numbers in regions with 3 or fewer dermatologists are published only as a range: at the bottom of every range the count would be 60, at the top 88.
87 of 88
home to 98% of eligible adults
Net cost a year
Average yearly cost over a 10-year programme, not discounted, compared with today's skin checks: risk assessment, checks and follow-up, minus the yearly checks of regular checkers that the programme replaces and, if counted, the melanoma treatment avoided.
$17M
after the checks it replaces and the treatment it avoids
Cost per year of healthy life
The programme's extra cost over 10 years divided by the quality-adjusted life years (QALYs) it gains, with the lifetime consequences of the melanomas found. The health gain comes from adults who are not checked today; it is net of the harm of extra overdiagnoses, biopsies and excisions. When those harms outweigh the melanoma deaths averted, the result is shown as no net gain. Both are discounted at 5% a year, so this is not the yearly cost divided by yearly health gain. Lower is better. Australia has no official limit; about $50,000 is often used.
no net gain
overdiagnosis and procedures outweigh the deaths averted
How certain?working out the range…Each simulation draws the uncertain inputs of the cost and health model at once: how many adults already have regular skin checks, how far checks lower thick melanomas and raise thin and in situ ones (Aitken 2010, Whiteman 2022), how often the adults in those studies were checked, whether a melanoma found earlier is found in situ or at stage I, how long a melanoma can be found before it surfaces, how long one that would never cause harm stays detectable and how often a check finds either, how much of the stage shift is real rather than lead time, overdiagnosis, survival, biopsies and excisions per check, treatment and check prices, and the health lost per death, per advanced melanoma, per overdiagnosis and per biopsy or excision. The settings you choose (threshold, who does the checks, how often, attendance, ages, the risk-assessment cost) are held fixed.
Costs and health effects are for a 10-year programme, with the lifetime consequences of the melanomas found during it. Workforce is 2024.
Can each region deliver?
Scroll to zoom · drag to pan · click a region
Can deliverOver the limit (up to 20% of a workforce's time)Well over the limit
Choose a region from the list, or click the map, to see whether it can deliver at this threshold and the lowest threshold it could manage.
ATOF is a modelling tool for planning and research, not a clinical decision aid. Results are preliminary and not yet peer reviewed. For the full controls, charts and per-person cost-effectiveness, open the detailed view.